Skip to Main Content

Author Details

Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
2008
61
26
Prashant Mali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36373171Single-cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate.Prostate2023
34385337Blind Image Restoration Enhances Digital Autoradiographic Imaging of Radiopharmaceutical Tissue Distribution.J Nucl Med2022
35906379[<sup>18</sup>F]-Labeled PARP-1 PET imaging of PSMA targeted alpha particle radiotherapy response.Sci Rep2022
35174853K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications.Dis Model Mech2022
33837069Improved Radium-223 Therapy with Combination Epithelial Sodium Channel Blockade.J Nucl Med2021
32232146Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancer.Sci Adv2020
32016503Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model.Cancer Immunol Immunother2020
33238985Significantly delayed polyglactin 910 suture-related pseudoinfection in a Yucatan pig.BMC Vet Res2020
32943549Microparticle Encapsulation of a Prostate-targeted Biologic for the Treatment of Liver Metastases in a Preclinical Model of Castration-resistant Prostate Cancer.Mol Cancer Ther2020
32938629Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia.J Immunother Cancer2020
32761950A hemi-spleen injection model of liver metastasis for prostate cancer.Prostate2020
32182119Preclinical Single Photon Emission Computed Tomography of Alpha Particle-Emitting Radium-223.Cancer Biother Radiopharm2020
30656716PSMA expression in the Hi-Myc model; extended utility of a representative model of prostate adenocarcinoma for biological insight and as a drug discovery tool.Prostate2019
31839878A mouse model of prostate cancer bone metastasis in a syngeneic immunocompetent host.Oncotarget2019
31795835Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer.Int J Hyperthermia2019
30171258Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer.Oncogene2019
31574039Characterization of Clinical and Histological Rejection of Male Genital Tissues Using a Novel Microsurgical Rat Penile Transplantation Model.Transplantation2019
31123087Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression.Cancer Res2019
30885287Poxvirus Infection in a Colony of Laboratory Pigeons (<i>Columba livia</i>).Comp Med2019
31131348Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate Cancer.JCO Precis Oncol2019
29324844Absence of myeloid Klf4 reduces prostate cancer growth with pro-atherosclerotic activation of tumor myeloid cells and infiltration of CD8 T cells.PLoS One2018
30130254O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis.J Clin Invest2018
29800797The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates.Nucl Med Biol2018
29556048Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer.Prostate Cancer Prostatic Dis2018
27801901Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis.Prostate Cancer Prostatic Dis2017
28484075TWIST1-WDR5-<i>Hottip</i> Regulates <i>Hoxa9</i> Chromatin to Facilitate Prostate Cancer Metastasis.Cancer Res2017
28435870Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation.Sci Adv2017
29254183Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma.Oncotarget2017
29177185A Murine Orthotopic Allograft to Model Prostate Cancer Growth and Metastasis.Bio Protoc2017
28747635AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination.Nat Commun2017
28823870Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction.Am J Pathol2017
27017984Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy.Gynecol Oncol2016
26446945Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer.Clin Cancer Res2016
25348195A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression.J Pathol2015
26294211Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression.Cancer Res2015
26056890IDENTIFICATION OF MYCOBACTERIUM GENAVENSE IN A DIANA MONKEY (CERCOPITHECUS DIANA) BY POLYMERASE CHAIN REACTION AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY.J Zoo Wildl Med2015
25990088Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at Multiple Sites.Cancer Prev Res (Phila)2015
24339398Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth.Adv Healthc Mater2014
25145668AEG-1 promoter-mediated imaging of prostate cancer.Cancer Res2014
24770967A novel viscous dissecting gel for endoscopic submucosal dissection: a prospective survival study in a porcine model.Endoscopy2014
24737393Notch signaling in prostate cancer: a moving target.Prostate2014
24816829Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer model.Drug Deliv Transl Res2014
23530114Tumorigenic potential of circulating prostate tumor cells.Oncotarget2013
24260246Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice.PLoS One2013
23610450Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee.Cancer Res2013
22182747Enhancement of airway gene transfer by DNA nanoparticles using a pH-responsive block copolymer of polyethylene glycol and poly-L-lysine.Biomaterials2012
23272373Mycobacterium abscessus pneumonia in an Atlantic bottlenose dolphin (Tursiops truncatus).J Zoo Wildl Med2012
22960283Wnt signaling though beta-catenin is required for prostate lineage specification.Dev Biol2012
22761195Sox9 is required for prostate development and prostate cancer initiation.Oncotarget2012
22927397Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.Proc Natl Acad Sci U S A2012
  • 1 - 50 of 61

Recommended Authors

Roswell Park Comprehensive Cancer Center
Career Start Year 2010
Number of shared co-authors 5
University of Texas Southwestern Medical Center
Career Start Year 2008
Number of shared co-authors 0
University of California los angeles
Career Start Year 2008
Number of shared co-authors 6
University of British Columbia
Career Start Year 2008
Number of shared co-authors 9
School of Pharmacy, University of Wisconsin-Madison
Career Start Year 2008
Number of shared co-authors 8
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 0
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 11
University of British Columbia
Career Start Year 2004
Number of shared co-authors 9
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 13
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 3
University of Toronto
Career Start Year 2002
Number of shared co-authors 1
University of British Columbia
Career Start Year 2002
Number of shared co-authors 18
University of British Columbia
Career Start Year 2000
Number of shared co-authors 18
Peter MacCallum Cancer Centre
Career Start Year 1999
Number of shared co-authors 1
University College London
Career Start Year 1999
Number of shared co-authors 2
Cedars-Sinai Medical Center
Career Start Year 1997
Number of shared co-authors 4
University of Washington School of Medicine
Career Start Year 1996
Number of shared co-authors 20
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 1
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 4
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 24
Georgetown University
Career Start Year 1993
Number of shared co-authors 1
David Geffen School of Medicine at university of california los angeles
Career Start Year 1993
Number of shared co-authors 25
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 3
Schulich School of Medicine and Dentistry, University of Western Ontario
Career Start Year 1989
Number of shared co-authors 1
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 9
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 14
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 7
MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 3
University of Utah
Career Start Year 1986
Number of shared co-authors 16
University of Washington
Career Start Year 1974
Number of shared co-authors 13

Collaborators

Northwestern University Feinberg School of Medicine
Co-authored papers 15
Northwestern University
Co-authored papers 12
Queen's University
Co-authored papers 10
Weill-Cornell School of Medicine
Co-authored papers 7
University of Maryland School of Medicine
Co-authored papers 6
Veracyte Inc.
Co-authored papers 5
Vanderbilt University Medical Center
Co-authored papers 4
Fred Hutchinson Cancer Center
Co-authored papers 4
GenomeDx Biosciences Inc.
Co-authored papers 4
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 3
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 3
Montefiore Medical Center
Co-authored papers 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Co-authored papers 2
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 2
Washington University in St. Louis
Co-authored papers 2
Johns Hopkins School of Medicine
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Johns Hopkins University School of Medicine
Co-authored papers 2
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Co-authored papers 2
Co-authored papers 2
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Johns Hopkins University School of Medicine
Co-authored papers 1
University of California Davis Health
Co-authored papers 1